期刊文献+

基质金属蛋白酶组织抑制剂在心脏中的表达及意义 被引量:1

Expression and Function of Tissue Inhibitor of Matrix Metalloproteinases in Heart
下载PDF
导出
摘要 基质金属蛋白酶组织抑制剂在心血管疾病发生发展过程中的变化是近年来心血管领域研究的热点之一。现就基质金属蛋白酶抑制剂的分类和结构及在心肌重构、心力衰竭、心肌缺血再灌注损伤等的表达及作用作一综述。 The changes of tissue inhibitor of matrix metalloproteinases. ( TIMPs) during occurence and development of cardiovascular diseases is one of the hottest research points in cardiovascular field recently. The review summarized the style and structure of TIMPs and its expression and function in myocardial reconstruction and heart failure and myocardiac ischemia reperfusion injury.
出处 《心血管病学进展》 CAS 2005年第B08期109-111,共3页 Advances in Cardiovascular Diseases
关键词 基质金属蛋白酶组织抑制剂 心肌重构 心力衰竭 心肌缺血再灌注 Tissue inhibitor of matrix metalloproteinases Myocardial reconstruction Heart failure Myocardiac ischemia-reperfusion
  • 相关文献

参考文献16

  • 1Trim JE,Samra SK,Arthur MJP,et al. Upstream tissue inhibitor of metalloproteinases-1 (T1MP-1) element-1 ,A novel and essential regulatory DNA motif in the human TIMP-1 gene promoter,directly interacts with a 30-kDa nuclear protein[ J ]. J Biol Chem ,2000,275 (9) :6657-6663.
  • 2Zhong ZD, Hammani K, Bae WS,et al. NF-Y and Spl cooperate for the transcriptional activation and cAMP response of human tissue inhibitor of metalloproteinase-2 [ J ]. J Biol Chem ,2000,275 ( 24 ) : 18602-18610.
  • 3Noji Y, Kajinami K, Kawashini MA, et al. Circulating matrix metalloproteinase and their inhibitors in premature coronary atheroselerosis [ J ]. Clin Chem Lab Med ,2001,39:380-384.
  • 4Li YY, Feldman AM, Sun Y, et al. Differential expression of tissue inhibitor of metalloproteinases in the failing human heart [ J ]. Circulation, 1998,98 : 1728-1734.
  • 5Costas J, Wang W J, Wilma L,et al. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinase during acute myocardial ischemiareperfusion injury[ J]. Circulation ,2003,107:2487.
  • 6Tummalapalli CM, Heath BJ, Tyagi SC. Tissue inhihitor of metalloproteinase-4 instigates apoptosis in transfomed cardiac fibroblasts[ J ]. J Cell Biochem ,2001,80:512-521.
  • 7Peterson JT, Li H, Dillon L, et al. Evalution of matrix metalloproteinase and tissue inhibitor expression during heart failure progression in the infarcted rat[ J ].Cardiovasc Res ,2000,46 : 307-315.
  • 8Heymans S, Luttun A, Nuyens D, et al. Inhibitor of plasminogen activators or matrix metalloproteinase prevents cardiac repture but impairs therapeutic angiogenesis and causes cardiac failure [ J ]. Nat Med, 1999,5 : 1135-1142.
  • 9Blindt R, Vogt F, Lamby D ,et al. Characterization of differential gene expression in quiescent and invasive human arterial smooth muscle cells [ J ]. J Vasc Res,2002,39:340-352.
  • 10Rao VU, Spinate FG. Controlling m yocardial matrix remodeling : implications for heart failure[ J]. Cardiol Rev, 1999,7:136-143.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部